Physician profile
Darius F Mitchell
NPI 1992780738
$12,260.84
in general payments reported to CMS, 2019-2025
13 companies · $1,945 in 2025
The $1,945 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $1,817 · 2021: $2,938 · 2022: $1,788 · 2023: $1,169 · 2024: $1,598 · 2025: $1,945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,418 · Food and Beverage: $1,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,418.36 |
| Food and Beverage | $1,294.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,668.47 | 2019-2025 | Arthrex |
| Midsouth Orthopedics INC. | $4,622.30 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $307.65 | 2019-2022 | |
| Vericel Corporation | $256.91 | 2021-2025 | Maci |
| Bioventus LLC | $175.95 | 2020-2025 | Durolane, Durolane, Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $59.79 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $44.86 | 2021-2022 | |
| Depuy Synthes Sales INC. | $44.78 | 2021-2022 | |
| Stryker Corporation | $25.85 | 2020 | |
| Molnlycke Health Care US, LLC | $18.11 | 2020 | |
| Sanofi-Aventis U.S. LLC | $15.16 | 2022 | |
| Horizon Therapeutics Plc | $10.90 | 2019 | |
| Arteriocyte Medical Systems, INC. | $10.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darius Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.